On November 20, 3SBIO fell 4.25% in Regular Trading, trading at HK$12.56, with turnover of HK$38.52 million.
The clearest recent catalyst in public disclosures is BlackRock's stake reduction, which has continued to pressure market sentiment despite the company's earlier share buybacks.
BlackRock disclosed that it disposed of 6.2852 million 3SBIO shares on November 12 through an off-exchange transaction, reducing its long position ratio from 6.23% to 5.98%. The filing stated the consideration involved non-cash assets and that the trade was not matched on the exchange's open market, meaning it was not a direct secondary-market sale. Earlier company filings showed 3SBIO repurchased a total of 6.3375 million shares from October 8 to 14 at HK$14.40 to HK$15.59 per share and held them as treasury shares, but recent trading indicates those buybacks have provided limited support to the stock.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments